These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3998998)

  • 1. Assessment of drug absorption after oral administration.
    Chan KK; Gibaldi M
    J Pharm Sci; 1985 Apr; 74(4):388-93. PubMed ID: 3998998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating drug absorption after oral administration. Some problems and some solutions.
    Chan KK; Gibaldi M
    Eur J Clin Pharmacol; 1984; 26(2):255-9. PubMed ID: 6723766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vivo drug release by numerical deconvolution using oral solution data as weighting function.
    Chan KK; Langenbucher F; Gibaldi M
    J Pharm Sci; 1987 Jun; 76(6):446-50. PubMed ID: 3625488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.
    Zeng YL; Akkermans AA; Breimer DD
    Arzneimittelforschung; 1983; 33(5):757-60. PubMed ID: 6688184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of absorption rate constant (ka) following oral administration by Wagner-Nelson, Loo-Riegelman, and statistical moments in the presence of a secondary peak.
    Mahmood I
    Drug Metabol Drug Interact; 2004; 20(1-2):85-100. PubMed ID: 15283305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.
    Garrison KL; Sahin S; Benet LZ
    J Pharm Sci; 2015 Sep; 104(9):3229-35. PubMed ID: 26010239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between drug input and mean residence time in the body.
    Bialer M; Look ZM; Silber BM; Yacobi A
    Biopharm Drug Dispos; 1986; 7(6):577-83. PubMed ID: 3828487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.
    Wagner JG
    J Pharmacokinet Biopharm; 1976 Oct; 4(5):395-425. PubMed ID: 1003327
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of the Loo-Riegelman absorption method.
    Wagner JG
    J Pharmacokinet Biopharm; 1975 Feb; 3(1):51-67. PubMed ID: 1127578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation.
    Wagner JG
    J Pharm Sci; 1983 Jul; 72(7):838-42. PubMed ID: 6887002
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of drug absorption by nonlinear regression, statistical moments, and Loo-Riegelman methods.
    Patel IH; Bornemann L; Colburn WA
    J Pharm Sci; 1985 Mar; 74(3):359-60. PubMed ID: 4009451
    [No Abstract]   [Full Text] [Related]  

  • 12. Microcomputer based pharmacokinetic programs for calculating absorption rate.
    Chan KK; Wnuck K
    Comput Programs Biomed; 1983; 16(1-2):27-33. PubMed ID: 6687853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. II. Log-concave concentration-time curves following oral administration.
    Weiss M
    J Pharmacokinet Biopharm; 1987 Feb; 15(1):57-74. PubMed ID: 3625480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calculation of different pharmacokinetic parameters from plasma data for a bicompartmental model of first order oral absorption].
    Fredj G; Clenet M; Rousselet F
    Therapie; 1978; 33(1):133-6. PubMed ID: 663893
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of the recirculation model: calculation of the amount of drug in the body from blood concentration data, with application to absorption rate calculations.
    Cutler DJ
    J Pharmacokinet Biopharm; 1981 Apr; 9(2):225-34. PubMed ID: 7277211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.
    Byron PR; Notari RE
    J Pharm Sci; 1976 Aug; 65(8):1140-4. PubMed ID: 978432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical moments in pharmacokinetics.
    Yamaoka K; Nakagawa T; Uno T
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):547-58. PubMed ID: 731417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.